Immunoadsorption therapy for steroid-unresponsive relapses in patients with multiple sclerosis

Blood Purification

Volumn 33, Issue 1-3, 2012, Pages 1-6

  Trebst, Corinna ^a   Bronzlik, Paul ^a   Kielstein, Jan T ^a   Schmidt, Bernhard M W ^a   Stangel, Martin ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Immunoadsorption; Multiple sclerosis; Relapse

Indexed keywords

METHYLPREDNISOLONE;

ADULT; ARTICLE; CATHETER COMPLICATION; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG MEGADOSE; DRUG TREATMENT FAILURE; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; HYPOTENSION; IMMUNOADSORPTION; MALE; MULTIPLE SCLEROSIS; OPTIC NEURITIS; PRIORITY JOURNAL; RELAPSE; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL ACUITY;

ADSORPTION; ADULT; EQUIPMENT DESIGN; FEMALE; HUMANS; IMMUNOGLOBULINS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PLASMA EXCHANGE; RECURRENCE; STEROIDS; YOUNG ADULT;

EID: 80855133015     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000332397     Document Type: Article

References (15)

1. McDonald WI: Relapse, remission, and progression in multiple sclerosis. N Engl J Med 2000; 343: 1486-1487.
2. Sellebjerg F, Barnes D, Filippini G, Midgard R, Montalban X, Rieckmann P, Selmaj K, Visser LH, Sorensen PS: EFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis relapses. Eur J Neurol 2005; 12:939-946.
3. Trebst C, Reising A, Kielstein JT, Hafer C, Stangel M: Plasma exchange therapy in steroid-unresponsive relapses in patients with multiple sclerosis. Blood Purif 2009; 28:108-115.
4. Weinshenker BG, O'Brien PC, Petterson TM, Noseworthy JH, Lucchinetti CF, Dodick DW, Pineda AA, Stevens LN, Rodriguez M: A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 1999; 46: 878-886.
5. Ruprecht K, Klinker E, Dintelmann T, Rieckmann P, Gold R: Plasma exchange for severe optic neuritis: treatment of 10 patients. Neurology 2004; 63:1081-1083.
6. Bennetto L, Totham A, Healy P, Massey E, Scolding N: Plasma exchange in episodes of severe inflammatory demyelination of the central nervous system: a report of six cases. J Neurol 2004; 251:1515-1521.
7. Schilling S, Linker RA, Konig FB, Koziolek M, Bahr M, Muller GA, Paulus W, Gartner J, Bruck W, Chan A, Gold R: Plasma exchange therapy for steroid-unresponsive multiple sclerosis relapses: clinical experience with 16 patients. Ner venarzt 2006; 77: 430-438.
8. Kurtzke JF: Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452.
9. Palm M, Behm E, Schmitt E, Buddenhagen F, Hitzschke B, Kracht M, Kundt G, Meyer-Rienecker H, Klinkmann H: Immunoad-sorption and plasma exchange in multiple sclerosis: complement and plasma protein behaviour. Biomater Artif Cells Immobilization Biotechnol 1991; 19: 283-296.
10. de Andres C, Anaya F, Gimenez-Roldan S: Plasma immunoadsorption treatment of malignant multiple sclerosis with severe and prolonged relapses. Rev Neurol 2000; 30: 601-605.
11. Schneidewind JM, Winkler R, Ramlow W, Tiess M, Hertel U, Sehland D: Immunoad-sorption-a new therapeutic possibility for multiple sclerosis? Tra nsfus Sci 1998; 19(sup-pl):59-63.
12. Klingel R, Heibges A, Fassbender C: Plasma exchange and immunoadsorption for autoimmune neurologic diseases-current guidelines and future perspectives. Athero-scler suppl 2009; 10:129-132.
13. Pittock SJ, Reindl M, Achenbach S, Berger T, Bruck W, Konig F, Morales Y, Lassmann H, Bryant S, Moore SB, Keegan BM, Lucchinet-ti CF: Myelin oligodendrocyte glycoprotein a ntibodies in patholog ica l ly proven mu ltiple sclerosis: frequency, stability and clinico-pat hologic correlations. Mult Scler 2007; 13: 7-16.
14. Rauer S, Euler B, Reindl M, Berger T: Anti-myelin antibodies and the risk of relapse in patients with a primary demyelinating event. J Neurol Neurosurg Psychiatry 2006; 77: 739-742.
15. Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodr ig uez M, L a ssmann H: He terogeneit y of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000; 47:707-717.